Bank of England set to hike interest rates to 4% to tackle rising inflation
The Bank of England is poised to hike interest rates for the first time in more than three…
AMD’s AI megadeals with OpenAI and Meta just cost it $1.1 billion: Chart of the Day
OpenAI (OPAI.PVT) and Meta (META) could buy 320 million AMD (AMD) shares for a penny apiece. That’s $3.2…
UK scam victim gets nearly $21,000 back from her bank. Canadian hit by same scam gets nothing
Photo Credit: iStock Two people lost money to nearly identical bank-card scams, but only one was reimbursed, highlighting…
Millions in UK set for higher mortgage costs next year as interest rate rise imminent
Households in Britain are bracing themselves as the Bank of England is looking set to raise interest rates…
Can These 4 ETFs Build a Retirement Portfolio on Their Own?
Vanguard’s founder John Bogle believed most actively managed funds and individual stocks couldn’t beat the S&P 500 (SNPINDEX:…
Apple could owe iPhone owners up to $95. Here’s how to claim it.
Apple Inc., which is scheduled to report earnings after the market close on Monday, agreed to a $250…
Apple has turned into Wall Street’s hedge against the AI trade: Chart of the Day
When AI stocks get hit, investors have found a place to hide. It’s the company that has mostly…
FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlight
Regeneron and Alnylam’s Cemdisiran showed significant improvements in daily functioning and muscle strength in a Phase 3 trial.…
Gen Z doesn’t think their degrees will land them work anymore, so they’re becoming their own bosses instead—and these college towns are thriving
College degrees are increasingly leaving graduates questioning whether the time and money were worth it as underemployment, unemployment,…
Amazon’s AI build-out just pushed its cash burn to a record: Chart of the Day
Wall Street spent the week punishing Big Tech’s biggest AI spenders. Amazon (AMZN) just posted the deepest cash…
How Are LLY’s Neuroscience and Immunology Drugs Poised Ahead of Q3?
Eli Lilly’s LLY portfolio is overwhelmingly driven by its popular GLP-1 medicines, Mounjaro and Zepbound. However, Neuroscience and…
How young earners can start investing and build long-term wealth
For young investors, building wealth is not simply about picking stocks or mutual funds that promise high returns.…